In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

A new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children’s Hospital Los ...

Researchers at Washington University found that stimulating meningeal lymphatic vessels in aged mice improved memory ...

For years, scientists studying brain aging have focused on proteins and DNA. But what if a crucial piece of the puzzlehas ...

The blood-brain barrier is a network of blood vessels and tissues that acts as a protective shield, preventing harmful substances in the blood from reaching the brain. In Alzheimer’s disease, this ...

Scientists performed a first-ever clinical test of the therapy avapritinib in pediatric patients with high-grade glioma. They ...

High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to FDA-approved avapritinib. | Drug Discovery And Development ...

CAR-T has been used to treat certain blood cancers for two decades and got its first Food and Drug ... brain presents additional challenges. The brain is surrounded by a difficult-to-penetrate ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric ...

Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side ...